Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleWellnessMD vs Vea Health

TeleWellnessMD
Graded #465

Lower grade

vs+1.3999999999999986
Vea Health
Graded #450

Higher grade

The verdict

Vea Health takes it — 55/100 to 53.6/100, but only just.

Vea Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vea Health is a direct-to-consumer telehealth platform aimed at men's health, performance, and longevity, offering compounded semaglutide and tirzepatide in both oral and injection protocols. TeleWellnessMD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationVea Health +11
40
51
Clinical oversightTeleWellnessMD +10
76
66
Labs & monitoringEven
52
52
FulfillmentVea Health +10
58
68
Contract termsEven
55
55
TeleWellnessMD · left barVea Health · right bar

The numbers

MetricTeleWellnessMDVea Health
WeighScore53.6/10055/100
GradeCC
Scorecard rank#465#450
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
TeleWellnessMD

Graded #465 · C

Strengths

  • Offers both semaglutide and tirzepatide within an established broader telehealth and wellness catalog
  • Licensed-provider assessment model with a 20 percent first-order discount for new patients
  • Phone support line published (877-659-6050)

Where it loses points

  • No per-month GLP-1 pricing published; price is assessment-gated
  • Compounding pharmacy is not named publicly
  • State availability is restricted and not enumerated
Vea Health

Graded #450 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard